• Something wrong with this record ?

Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients

M. Boudna, T. Machackova, P. Vychytilova-Faltejskova, K. Trachtova, R. Bartosova, T. Catela Ivkovic, D. Al Tukmachi, R. Jugas, L. Pifkova, J. Orlickova, J. Kotoucek, M. Pavlikova, M. Sachlova, L. Bohovicova, T. Stanek, J. Halamkova, I. Kiss, T....

. 2024 ; 24 (1) : 67. [pub] 20240403

Language English Country Italy

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24014372

Grant support
20-18889S Grantová Agentura České Republiky
20-18889S Grantová Agentura České Republiky
20-18889S Grantová Agentura České Republiky

Colorectal cancer (CRC) is the second most prevalent cancer type worldwide, which highlights the urgent need for non-invasive biomarkers for its early detection and improved prognosis. We aimed to investigate the patterns of long non-coding RNAs (lncRNAs) in small extracellular vesicles (sEVs) collected from low-volume blood serum specimens of CRC patients, focusing on their potential as diagnostic biomarkers. Our research comprised two phases: an initial exploratory phase involving RNA sequencing of sEVs from 76 CRC patients and 29 healthy controls, and a subsequent validation phase with a larger cohort of 159 CRC patients and 138 healthy controls. Techniques such as dynamic light scattering, transmission electron microscopy, and Western blotting were utilized for sEV characterization. Optimized protocol for sEV purification, RNA isolation and preamplification was applied to successfully sequence the RNA content of sEVs and validate the results by RT-qPCR. We successfully isolated sEVs from blood serum and prepared sequencing libraries from a low amount of RNA. High-throughput sequencing identified differential levels of 460 transcripts between CRC patients and healthy controls, including mRNAs, lncRNAs, and pseudogenes, with approximately 20% being lncRNAs, highlighting several tumor-specific lncRNAs that have not been associated with CRC development and progression. The validation phase confirmed the upregulation of three lncRNAs (NALT1, AL096828, and LINC01637) in blood serum of CRC patients. This study not only identified lncRNA profiles in a population of sEVs from low-volume blood serum specimens of CRC patients but also highlights the value of innovative techniques in biomolecular research, particularly for the detection and analysis of low-abundance biomolecules in clinical samples. The identification of specific lncRNAs associated with CRC provides a foundation for future research into their functional roles in cancer development and potential clinical applications.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014372
003      
CZ-PrNML
005      
20240905133835.0
007      
ta
008      
240725s2024 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10238-024-01323-1 $2 doi
035    __
$a (PubMed)38568288
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Boudna, Marie $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
245    10
$a Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients / $c M. Boudna, T. Machackova, P. Vychytilova-Faltejskova, K. Trachtova, R. Bartosova, T. Catela Ivkovic, D. Al Tukmachi, R. Jugas, L. Pifkova, J. Orlickova, J. Kotoucek, M. Pavlikova, M. Sachlova, L. Bohovicova, T. Stanek, J. Halamkova, I. Kiss, T. Grolich, M. Svoboda, Z. Kala, K. Souckova, O. Slaby
520    9_
$a Colorectal cancer (CRC) is the second most prevalent cancer type worldwide, which highlights the urgent need for non-invasive biomarkers for its early detection and improved prognosis. We aimed to investigate the patterns of long non-coding RNAs (lncRNAs) in small extracellular vesicles (sEVs) collected from low-volume blood serum specimens of CRC patients, focusing on their potential as diagnostic biomarkers. Our research comprised two phases: an initial exploratory phase involving RNA sequencing of sEVs from 76 CRC patients and 29 healthy controls, and a subsequent validation phase with a larger cohort of 159 CRC patients and 138 healthy controls. Techniques such as dynamic light scattering, transmission electron microscopy, and Western blotting were utilized for sEV characterization. Optimized protocol for sEV purification, RNA isolation and preamplification was applied to successfully sequence the RNA content of sEVs and validate the results by RT-qPCR. We successfully isolated sEVs from blood serum and prepared sequencing libraries from a low amount of RNA. High-throughput sequencing identified differential levels of 460 transcripts between CRC patients and healthy controls, including mRNAs, lncRNAs, and pseudogenes, with approximately 20% being lncRNAs, highlighting several tumor-specific lncRNAs that have not been associated with CRC development and progression. The validation phase confirmed the upregulation of three lncRNAs (NALT1, AL096828, and LINC01637) in blood serum of CRC patients. This study not only identified lncRNA profiles in a population of sEVs from low-volume blood serum specimens of CRC patients but also highlights the value of innovative techniques in biomolecular research, particularly for the detection and analysis of low-abundance biomolecules in clinical samples. The identification of specific lncRNAs associated with CRC provides a foundation for future research into their functional roles in cancer development and potential clinical applications.
650    _2
$a lidé $7 D006801
650    12
$a RNA dlouhá nekódující $x genetika $7 D062085
650    _2
$a sérum $7 D044967
650    12
$a extracelulární vezikuly $x genetika $7 D000067128
650    12
$a sekundární malignity $7 D016609
650    _2
$a biologické markery $7 D015415
650    12
$a kolorektální nádory $x diagnóza $x genetika $7 D015179
655    _2
$a časopisecké články $7 D016428
700    1_
$a Machackova, Tana $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Vychytilova-Faltejskova, Petra $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Trachtova, Karolina $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Bartosova, Renata $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Catela Ivkovic, Tina $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Al Tukmachi, Dagmar $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Jugas, Robin $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Pifkova, Lucie $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Orlickova, Jana $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Kotoucek, Jan $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Pavlikova, Marketa $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Sachlova, Milana $u Department of Gastroenterology and Digestive Endoscopy, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Bohovicova, Lucia $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Stanek, Teodor $u Department of Surgical Oncology, Faculty of Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Halamkova, Jana $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Kiss, Igor $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Grolich, Tomas $u Department of Surgery, Faculty of Medicine, University Hospital Brno Bohunice, Masaryk University, Brno, Czech Republic
700    1_
$a Svoboda, Martin $u Department of Surgery, Faculty of Medicine, University Hospital Brno Bohunice, Masaryk University, Brno, Czech Republic
700    1_
$a Kala, Zdenek $u Department of Surgery, Faculty of Medicine, University Hospital Brno Bohunice, Masaryk University, Brno, Czech Republic
700    1_
$a Souckova, Kamila $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. kamgenet@gmail.com
700    1_
$a Slaby, Ondrej $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. oslaby@med.muni.cz $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. oslaby@med.muni.cz
773    0_
$w MED00006222 $t Clinical and experimental medicine $x 1591-9528 $g Roč. 24, č. 1 (2024), s. 67
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38568288 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133829 $b ABA008
999    __
$a ok $b bmc $g 2143879 $s 1226238
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 24 $c 1 $d 67 $e 20240403 $i 1591-9528 $m Clinical and experimental medicine $n Clin Exp Med $x MED00006222
GRA    __
$a 20-18889S $p Grantová Agentura České Republiky
GRA    __
$a 20-18889S $p Grantová Agentura České Republiky
GRA    __
$a 20-18889S $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Archiving options